`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`
`Inter Partes Review No.: IPR2021-00881
`
`
`U.S. Patent No. 9,254,338 B2
`Filed: July 12, 2013
`Issued: February 9, 2016
`Inventor: George D. Yancopoulos
`
`Title: USE OF A VEGF ANTAGONIST TO TREAT
`ANGIOGENIC EYE DISORDERS
`
`
`PETITIONER MYLAN PHARMACEUTICALS INC.’S
`UPDATED POWER OF ATTORNEY PURSUANT TO 37 C.F.R. § 42.10(b)
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Mylan Pharmaceuticals Inc.
`
`hereby appoints the following practitioners as its attorneysto transactall businessin
`
`the United States Patent & Trademark Office associated with its Petition for Jnter
`
`Partes Review of U.S. Patent No. 9,254,338 B2:
`
`wrakoczy@rmmslegal.com Deanne M. Mazzochi (Reg. No. 50,158)
`
`Lead Counsel
`
`Paul J. Molino (Reg. No. 45,350)
`paul@rmmslegal.com
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West HubbardStreet
`Chicago, IL 60654
`Telephone: (312) 222-6300
`Facsimile: (312) 843-6260
`
`Petitioner consents to email service at:
`MYLREGIPR@rmmslegal.com
`
`
`
`Backup Counsel
`
`William A. Rakoczy
`(admitted pro hac vice)
`
`dmazzochi@rmmslegal.com
`
`Heinz J. Salmen
`(admitted pro hac vice)
`hsalmen@rmmslegal.com
`
`Jeff A. Marx (Reg. No. 56,977)
`jmarx@rmmslegal.com
`
`Eric R. Hunt
`(pro hac vice to be filed)
`ehunt@rmmslegal.com
`
`Neil B. McLaughlin (Reg. No. 70,810)
`nmclaughlin@rmmslegal.com
`
`L. Scott Beall (Reg. No. 52,601)
`sbeall@rmmslegal.com
`
`Thomas H.Ehrich (Reg. No. 67,122)
`tehrich@rmmslegal.com
`
`
`
`Steven J. Birkos (Reg. No. 65,300)
`sbirkos@rmmslegal.com
`
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 527-5127
`Facsimile: (312) 843-6260
`
`
`
`
`
`
`The individual signing below has the authority to execute this document on
`
`behalf of Mylan Pharmaceuticals Inc.
`
`
`
`Mylan Pharmaceuticals Inc.
`
`
`
`
`
`By: ____________________________
`
`Name: ______Vinny Lee____________
`
`Title: ____Litigation Counsel________
`
`Date: ______April 19, 2022_________
`
`
`
`
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersignedherebycertifies that a true and correct copy of the foregoing
`
`Petitioner Mylan Pharmaceuticals Inc.’s Updated Power of Attorney Pursuant to 37
`
`C.F.R. § 42.10(b) was served on April 20, 2022, via electronic mail by agreementof
`
`the parties, to the following counsel for record of Patent Owners:
`
`Deborah E. Fishman (Reg. No. 48,621)
`David A. Caine (Reg. No. 52,683)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Telephone: 650.319.4710
`Facsimile: 650.319.4573
`Deborah.Fishman@arnoldporter.com
`David.Caine@arnoldporter.com
`RegeneronEyleaIPRs@arnoldporter.com
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines
`Jeremy Cobb
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Fax: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Jeremy.Cobb@arnoldporter.com
`
`Daniel Reisner
`Matthew M.Wilk
`Arnold & Porter Kaye Scholer LLP
`250 West 55th Street
`New York, New York 10019-9710
`Telephone: 212.836.8000
`Fax: 212.836.8689
`Daniel.Reisner@arnoldporter.com
`Matthew.Wilk@arnoldporter.com
`
`/Paul J. Molino/
`Paul J. Molino (Reg. No. 45,350)
`
`